We are excited to announce the launch of BARDA’s VITAL program! (Vaccine Innovation & Therapeutics Acceleration Launchpad) Program details can be found in the attached pdf.
BioLabs is collaborating with BARDA to execute two amazing programs: the Biotech Accelerator & Non-Dilutive Funding Opportunities. Enrollment for both programs is now OPEN and companies, academics, and individuals are all welcome to apply through August 23, 2024.
The @VITAL – A BARDA BAN Hub Biotech Accelerator Program is looking for groundbreaking startups and university projects focusing on therapeutics and vaccines to fight pandemics and strengthen global health security.
Program Highlights:
🔬 Expert Mentoring: Receive personalized guidance tailored to your company’s needs.
🌐 Extensive Network: Connect with over 250 healthtech and biotech mentors.
💰 No Cost, No Equity: Take advantage of a fully funded, equity-free program.
This is your opportunity to spearhead global health solutions and be part of an esteemed program and network of innovators. Apply to the VITAL Biotech Accelerator Program and make a difference worldwide! Application Deadline: August 23, 2024. 👉 https://vitalhubhealth.com/biotech-accelerator-program/
For those of you working on groundbreaking therapeutics or vaccine solutions, this is also your chance to receive non-dilutive funding ranging from $50K to $200K made available through @VITAL – A BARDA BAN Hub to advance your global health solutions.
This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. Startups and projects will receive project management support and mentoring from subject matter experts over the award duration of up to 6 months.
Don’t miss this incredible opportunity to accelerate your project and make a significant impact on pandemic preparedness and health security. Apply now until August 23, 2024: https://vitalhubhealth.com/funding/